<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39465096</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0018-5787</ISSN><JournalIssue CitedMedium="Print"><Volume>59</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Hospital pharmacy</Title><ISOAbbreviation>Hosp Pharm</ISOAbbreviation></Journal><ArticleTitle>A Novel Common Canister Protocol for Albuterol Sulfate Metered Dose Inhalers: Conservation Strategy and Clinical Outcomes Amid COVID-19 Pandemic.</ArticleTitle><Pagination><StartPage>631</StartPage><EndPage>637</EndPage><MedlinePgn>631-637</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/00185787241254994</ELocationID><Abstract><AbstractText>The COVID-19 pandemic led to unprecedented shortages of albuterol sulfate metered dose inhalers (MDIs) utilized in the supportive management of respiratory symptoms in patients with SARS-CoV-2 infections. The risk of generating infective aerosols in nebulized treatments increased the demand for metered dose delivery, leading to a worldwide shortage of albuterol sulfate MDIs. Previous common canister protocols involve the recycling and cleaning of canisters for multiple patient use, however have not undergone quality control studies on viral cross-contamination. Torrance Memorial Medical Center utilized an off-label method of common canister administration through spacer devices, forgoing the need for sterilization while conserving albuterol sulfate during a public health emergency. A retrospective review of this emergency department protocol was conducted on 329 patients receiving this novel albuterol sulfate common canister method over a 10-month period between 3/23/2020 to 1/23/2021. Results showed 265 patients (80.5%) had improved aeration determined by breath sounds evaluation by the respiratory therapist and patient interview. Purchasing records reviewed since 3/1/2020 show purchases were sufficient to sustain albuterol sulfate MDI supply so that no treatments were delayed omitted during the 10-month evaluation period. This novel approach to common canister delivery offers a promising measure to conserve a vital inhaled medication during a public health emergency and could serve as a basis for future development of conservation and quality control studies.</AbstractText><CopyrightInformation>© The Author(s) 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Mei</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0004-5206-0678</Identifier><AffiliationInfo><Affiliation>Torrance Memorial Medical Center, Torrance, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suggett</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Trudell Medical International, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Co</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Torrance Memorial Medical Center, Torrance, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ginder</LastName><ForeName>Tammy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Torrance Memorial Medical Center, Torrance, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hosp Pharm</MedlineTA><NlmUniqueID>0043175</NlmUniqueID><ISSNLinking>0018-5787</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">drug/medical use evaluation</Keyword><Keyword MajorTopicYN="N">medication process</Keyword><Keyword MajorTopicYN="N">respiratory</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>5</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39465096</ArticleId><ArticleId IdType="pmc">PMC11500215</ArticleId><ArticleId IdType="doi">10.1177/00185787241254994</ArticleId><ArticleId IdType="pii">10.1177_00185787241254994</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Lexi-Drugs/Albuterol. UpToDate Lexidrug mobile app. UpToDate Inc. Accessed March 16, 2024. https://online.lexi.com/</Citation></Reference><Reference><Citation>Hui DS, Chow BK, Chu LCY, et al.. Exhaled air and aerosolized droplet dispersion during application of a jet nebulizer. Chest. 2009;135(3):648-654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094435</ArticleId><ArticleId IdType="pubmed">19265085</ArticleId></ArticleIdList></Reference><Reference><Citation>Payares-Salamanca L, Contreras-Arrieta S, Florez-García V, Barrios-Sanjuanelo A, Stand-Niño I, Rodriguez-Martinez CE. Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis. Pediatr Pulmonol. 2020;55:3268-3278.</Citation><ArticleIdList><ArticleId IdType="pubmed">32940961</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncada C, Andrade J, Bischoff LC, Pitrez PM. Comparison of two inhalation techniques for bronchodilator administration in children and adolescents with acute asthma crisis: a meta-analysis. Rev Paul Pediatr. 2018;36(3):364-371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6202895</ArticleId><ArticleId IdType="pubmed">29995144</ArticleId></ArticleIdList></Reference><Reference><Citation>
American Society of Health-System Pharmacists. Drug shortage list. 2020. Accessed November, 2020. https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=647</Citation></Reference><Reference><Citation>Liou J, Clyne K, Knapp D, Snyder J. Establishing a quality control program: ensuring safety from contamination for recycled metered-dose inhalers. Hosp Pharm. 2014;49(5):437-443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4062717</ArticleId><ArticleId IdType="pubmed">24958955</ArticleId></ArticleIdList></Reference><Reference><Citation>Amirav I, Newhouse MT. Transmission of coronavirus by nebulizer: a serious, underappreciated risk. CMAJ. 2020;192(13):E346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7124163</ArticleId><ArticleId IdType="pubmed">32392488</ArticleId></ArticleIdList></Reference><Reference><Citation>
COVID19 Pharmacy Practice Considerations. Vizient Inc. 2020. Accessed December 15, 2022. https://continuingeducation.vizientinc.com/sites/default/files/Final%20Pharmacy%20practice%20considerations%20webinar%201_MDI%20conservation%20COVID-19.pdf</Citation></Reference><Reference><Citation>McIvor RA, Devlin HM, Kaplan A. Optimizing the delivery of inhaled medication for respiratory patients: the role of valved holding chambers. Can Respir J. 2018;2018:5076259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5904796</ArticleId><ArticleId IdType="pubmed">29849831</ArticleId></ArticleIdList></Reference><Reference><Citation>
United States Pharmacopeia. Chapter &lt;601&gt;: inhalation and nasal drug products: aerosols, sprays, and powders—performance quality tests.Rockwell, MD, USA. 2024. Accessed April 18, 2024. https://uspnf.com/uspnf/</Citation></Reference><Reference><Citation>
United States Pharmacopeia. Chapter &lt;1602&gt;: spacers and valved holding chambers used with inhalation aerosols—characterization tests. Rockwell, MD, USA. 2024. Accessed April 18, 2024. https://uspnf.com/uspnf/</Citation></Reference><Reference><Citation>Rodrigo G, Rodrigo C. Early prediction of poor response acute asthma patients in the Emergency Department. Chest. 1998;114:1016-1021.</Citation><ArticleIdList><ArticleId IdType="pubmed">9792570</ArticleId></ArticleIdList></Reference><Reference><Citation>Ari A, Restrepo RD; American Association for Respiratory Care. Aerosol delivery device selection for spontaneously breathing patients: 2012. Respir Care. 2012;57(4):613-626.</Citation><ArticleIdList><ArticleId IdType="pubmed">22472501</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman KB, Milne S, Hamilton C, Hall K. A comparison of albuterol administered by metered-dose inhaler and spacer with albuterol by nebulizer in adults presenting to an urban emergency department with acute asthma. Chest. 2002;121(4):1036-1041.</Citation><ArticleIdList><ArticleId IdType="pubmed">11948030</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>